| Year |
Citation |
Score |
| 2024 |
Sillau SH, Coughlan C, Ahmed MM, Nair K, Araya P, Galbraith MD, Bettcher BM, Espinosa JM, Chial HJ, Epperson N, Boyd TD, Potter H. Neuron loss in the brain starts in childhood, increases exponentially with age and is halted by GM-CSF treatment in Alzheimer's disease. Medrxiv : the Preprint Server For Health Sciences. PMID 39072024 DOI: 10.1101/2024.07.14.24310223 |
0.468 |
|
| 2023 |
Stonedahl S, Leser JS, Clarke P, Potter H, Boyd TD, Tyler KL. Treatment with Granulocyte-Macrophage Colony-Stimulating Factor Reduces Viral Titers in the Brains of West Nile Virus-Infected Mice and Improves Survival. Journal of Virology. e0180522. PMID 36802227 DOI: 10.1128/jvi.01805-22 |
0.48 |
|
| 2022 |
Ahmed MM, Wang AC, Elos M, Chial HJ, Sillau S, Solano DA, Coughlan C, Aghili L, Anton P, Markham N, Adame V, Gardiner KJ, Boyd TD, Potter H. The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 down syndrome mice and improves learning/memory in wild-type mice. Neurobiology of Disease. 105694. PMID 35307513 DOI: 10.1016/j.nbd.2022.105694 |
0.524 |
|
| 2022 |
Potter H, Kendall L, Boyd T, Sillau S, Bosco-Lauth A, Markham N, Fong D, Clarke P, Tyler K. GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19. Research Square. PMID 35118463 DOI: 10.21203/rs.3.rs-1213395/v1 |
0.501 |
|
| 2021 |
Ahmed MM, Johnson NR, Boyd TD, Coughlan C, Chial HJ, Potter H. Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners? Frontiers in Aging Neuroscience. 13: 718426. PMID 34603007 DOI: 10.3389/fnagi.2021.718426 |
0.481 |
|
| 2021 |
Potter H, Woodcock JH, Boyd TD, Coughlan CM, O'Shaughnessy JR, Borges MT, Thaker AA, Raj BA, Adamszuk K, Scott D, Adame V, Anton P, Chial HJ, Gray H, Daniels J, et al. Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 7: e12158. PMID 33778150 DOI: 10.1002/trc2.12158 |
0.549 |
|
| 2020 |
Bubak AN, Beseler C, Como CN, Coughlan CM, Johnson NR, Hassell JE, Burnet AM, Mescher T, Schmid DS, Coleman C, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Shilleh AH, et al. Amylin, Aβ42, and Amyloid in VZV Vasculopathy Cerebrospinal Fluid and Infected Vascular Cells. The Journal of Infectious Diseases. PMID 32809013 DOI: 10.1093/Infdis/Jiaa513 |
0.492 |
|
| 2020 |
Potter H, Boyd TD, Clarke P, Pelak VS, Tyler KL. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19. F1000research. 9: 345. PMID 32704352 DOI: 10.12688/F1000Research.23729.1 |
0.489 |
|
| 2020 |
Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia-Perez JE, Adame V, Anton P, Bettcher BM, Chial HJ, Koenigshoff M, Hsieh EWY, Graner M, Potter H. Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses. Current Protocols in Cell Biology. 88: e110. PMID 32633898 DOI: 10.1002/Cpcb.110 |
0.323 |
|
| 2019 |
Bubak AN, Como CN, Coughlan CM, Johnson NR, Hassell JE, Mescher T, Niemeyer CS, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Russ HA, Nagel MA. Varicella Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-beta, and an Amyloidogenic Extracellular Environment. The Journal of Infectious Diseases. PMID 31665341 DOI: 10.1093/Infdis/Jiz560 |
0.492 |
|
| 2019 |
Pelak VS, Tang-Wai DF, Bouwman FH, Onyike CU, Murray ME, Day GS, Migliaccio R, Olds J, Hills W, Bretsch C, Lusk J, Potter H, Boyd T, Pressman PS, Holden SK, et al. P1-311: Development Of An International Posterior Cortical Atrophy Bioregistry Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.866 |
0.388 |
|
| 2017 |
Potter H, Woodcock JH, Boyd T, Sillau SH, Bettcher BM, Daniels J, Heffernan KS, Gray H. INTERIM REPORT OF A PHASE 2 PILOT SAFETY AND EFFICACY TRIAL OF GM-CSF/LEUKINE® IN MILD-TO-MODERATE ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P1572. DOI: 10.1016/J.Jalz.2017.07.735 |
0.499 |
|
| 2012 |
Jim HS, Boyd TD, Booth-Jones M, Pidala J, Potter H. Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients. Brain Disorders & Therapy. 1. PMID 22905341 DOI: 10.4172/2168-975X.1000101 |
0.444 |
|
| 2012 |
Boyd TD, Potter H. THE JOURNEY OF A POTENTIAL ALZHEIMER THERAPY FROM THE LABORATORY BENCH THROUGH THE PATENT OFFICE AND INTO THE CLINIC Technology & Innovation. 14: 365-380. DOI: 10.3727/194982412X13500042169216 |
0.406 |
|
| 2010 |
Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. Journal of Alzheimer's Disease : Jad. 21: 507-18. PMID 20555144 DOI: 10.3233/Jad-2010-091471 |
0.529 |
|
| 2009 |
Bennett SP, Boyd TD, Norden M, Padmanabhan J, Neame P, Wefes I, Potter H. A novel technique for simultaneous bilateral brain infusions in a mouse model of neurodegenerative disease. Journal of Neuroscience Methods. 184: 320-6. PMID 19732796 DOI: 10.1016/J.Jneumeth.2009.08.021 |
0.49 |
|
| 2006 |
Boyd T, Woodcock JH, Adame V, Sillau SH, Borges TT, Bettcher BM, Daniels J, Heffernan KS, Potter H. P4-203: INTERIM BIOMARKER ANALYSES OF PHASE II STUDY DATA ON SAFETY AND EFFICACY OF GM-CSF/LEUKINE®
IN MILD-TO-MODERATE AD Alzheimer's & Dementia. 14: P1517-P1518. DOI: 10.1016/J.Jalz.2018.07.024 |
0.5 |
|
| Show low-probability matches. |